Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

Study reveals new molecular mechanism linked to severe anaphylaxis

Study reveals new molecular mechanism linked to severe anaphylaxis

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

Commentary on severe allergic reaction to mRNA SARS-CoV-2 vaccines

Novel immunotherapy approach to revert the main hallmarks of cat allergy

Novel immunotherapy approach to revert the main hallmarks of cat allergy

Race may play an important role in children's food allergies

Race may play an important role in children's food allergies

Black children have significantly higher rates of shellfish and fish allergies than white children

Black children have significantly higher rates of shellfish and fish allergies than white children

Specific NSAIDs are metabolized by acyl-CoA synthetases leading to liver toxicity

Specific NSAIDs are metabolized by acyl-CoA synthetases leading to liver toxicity

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

COVID vaccines appear safe and effective, but key questions remain

COVID vaccines appear safe and effective, but key questions remain

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

FDA expands approved indication for influenza treatment to include post-exposure prevention

FDA expands approved indication for influenza treatment to include post-exposure prevention

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Allergy charities encourage parents, teachers to ‘Check It, Don’t Chance It’ to safeguard allergic children

Allergy charities encourage parents, teachers to ‘Check It, Don’t Chance It’ to safeguard allergic children

Powerful antimicrobial molecules engineered from toxic proteins in wasp venom

Powerful antimicrobial molecules engineered from toxic proteins in wasp venom

Holidays linked to severe spike in nut allergies among children

Holidays linked to severe spike in nut allergies among children

Allergic immune response against bacteria is not pathological but protective

Allergic immune response against bacteria is not pathological but protective

Inflammatory protein produced by mast cells contributes to fibrosis in gastric cancer

Inflammatory protein produced by mast cells contributes to fibrosis in gastric cancer

Cognitive behavioral therapy helps food allergic children with severe phobia of anaphylaxis

Cognitive behavioral therapy helps food allergic children with severe phobia of anaphylaxis

Human genome may explain the neonatal origins of chronic immune and inflammatory diseases

Human genome may explain the neonatal origins of chronic immune and inflammatory diseases

Pandemic-inspired food labeling raises alarms for those with food allergies

Pandemic-inspired food labeling raises alarms for those with food allergies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.